None N = 418 | Mild N = 1346 | Moderate N = 1070 | Severe N = 356 | |||||
---|---|---|---|---|---|---|---|---|
N | % | N | % | N | % | N | % | |
a. Characteristics of the subgroups—self-reported severity of arm swelling (N = 3190) | ||||||||
Country | ||||||||
Denmark | 334 | 79.9 | 1165 | 86.6 | 990 | 92.5 | 337 | 94.7 |
USA | 84 | 20.1 | 181 | 13.4 | 80 | 7.5 | 19 | 5.3 |
Age groups (years) | ||||||||
≤ 49 | 33 | 7.9 | 153 | 11.4 | 93 | 8.7 | 31 | 11.5 |
50–59 | 86 | 20.6 | 379 | 28.1 | 274 | 25.6 | 109 | 30.6 |
60–69 | 161 | 38.5 | 429 | 31.9 | 345 | 32.2 | 97 | 27.3 |
≥ 70 | 138 | 33.0 | 385 | 28.6 | 358 | 33.5 | 109 | 30.6 |
BMI (kg/m2) | ||||||||
Under/normal weight (< 25) | 180 | 43.1 | 558 | 41.5 | 377 | 35.2 | 98 | 27.5 |
Overweight (25–29) | 143 | 34.2 | 461 | 34.2 | 378 | 35.3 | 115 | 32.3 |
Obese (≥30) | 94 | 22.5 | 325 | 24.1 | 310 | 29.0 | 140 | 39.3 |
Missing | 1 | 0.2 | 2 | 0.2 | 5 | 0.5 | 3 | 0.9 |
Ethnicity | ||||||||
Caucasian | 370 | 88.5 | 1195 | 88.8 | 914 | 85.4 | 303 | 85.1 |
Other | 48 | 11.5 | 151 | 11.2 | 156 | 14.6 | 53 | 14.9 |
Time since lymphedema diagnosis | ||||||||
≤ 4 | 123 | 29.4 | 475 | 35.3 | 310 | 29.0 | 82 | 23.0 |
5–9 | 142 | 34.0 | 489 | 36.3 | 402 | 37.5 | 135 | 38.0 |
≥ 10 | 153 | 36.6 | 382 | 28.4 | 358 | 33.5 | 139 | 39.0 |
Lymphedema laterality | ||||||||
Unilateral | 413 | 98.8 | 1322 | 98.2 | 1044 | 97.6 | 345 | 96.9 |
Bilateral | 5 | 1.2 | 24 | 1.8 | 26 | 2.4 | 11 | 3.1 |
None N = 335 | Minor N = 2108 | Major N = 779 | ||||
---|---|---|---|---|---|---|
N | % | N | % | N | % | |
b. Characteristics of the subgroups—based on having a problem with the arm(s) as a result of breast cancer and/or its treatment (N = 3222) | ||||||
Country | ||||||
Denmark | 302 | 90.1 | 1865 | 88.5 | 691 | 88.7 |
USA | 33 | 9.9 | 243 | 11.5 | 88 | 11.3 |
Age groups (years) | ||||||
≤ 49 | 21 | 6.3 | 211 | 10.0 | 90 | 11.6 |
50–59 | 57 | 17.0 | 564 | 26.8 | 233 | 29.9 |
60–69 | 105 | 31.3 | 695 | 33.0 | 237 | 30.4 |
≥ 70 | 152 | 45.4 | 638 | 30.2 | 219 | 28.1 |
BMI (kg/m2) | ||||||
Under/normal weight (< 25) | 152 | 45.4 | 834 | 39.6 | 240 | 30.8 |
Overweight (25–29) | 114 | 34.0 | 734 | 34.8 | 259 | 33.3 |
Obese (≥30) | 67 | 20.0 | 534 | 25.3 | 276 | 35.4 |
Missing | 2 | 0.6 | 6 | 0.3 | 4 | 0.5 |
Ethnicity | ||||||
Caucasian | 292 | 87.2 | 1844 | 87.5 | 670 | 86.0 |
Other | 43 | 12.8 | 264 | 12.5 | 109 | 14.0 |
Time since lymphedema diagnosis | ||||||
≤ 4 | 94 | 28.1 | 683 | 32.4 | 221 | 28.4 |
5-9 | 132 | 39.4 | 774 | 36.7 | 277 | 35.6 |
≥ 10 | 109 | 32.5 | 651 | 30.9 | 281 | 36.0 |
Lymphedema laterality | ||||||
Unilateral | 330 | 98.5 | 2080 | 98.7 | 746 | 95.8 |
Bilateral | 5 | 1.5 | 28 | 1.3 | 33 | 4.2 |
No sleeve N = 940 | Sleeve N = 2282 | |||
---|---|---|---|---|
N | % | N | % | |
c. Characteristics of the subgroups—based on whether participant wore a compression sleeve in the past 12 months (N = 3222) | ||||
Country | ||||
Denmark | 807 | 85.9 | 2051 | 89.9 |
USA | 133 | 14.1 | 231 | 10.1 |
Age groups (years) | ||||
≤ 49 | 83 | 8.8 | 239 | 10.5 |
50–59 | 226 | 24.0 | 628 | 27.5 |
60–69 | 319 | 34.0 | 718 | 31.5 |
≥ 70 | 312 | 33.2 | 697 | 30.5 |
BMI (kg/m2) | ||||
Under/normal weight (< 25) | 350 | 37.2 | 876 | 38.4 |
Overweight (25–29) | 328 | 34.9 | 779 | 34.1 |
Obese (≥ 30) | 260 | 27.7 | 617 | 27.1 |
Missing | 2 | 0.2 | 10 | 0.4 |
Ethnicity | ||||
Caucasian | 811 | 86.3 | 1995 | 87.4 |
Other | 129 | 13.7 | 287 | 12.6 |
Time since lymphedema diagnosis | ||||
≤ 4 | 217 | 23.1 | 781 | 34.2 |
5–9 | 350 | 37.2 | 833 | 36.5 |
≥ 10 | 373 | 39.7 | 668 | 29.3 |
Lymphedema laterality | ||||
Unilateral | 913 | 97.1 | 2243 | 98.3 |
Bilateral | 27 | 2.9 | 39 | 1.7 |